The primary antidote for digoxin toxicity is digoxin-specific antibody fragments, a medication that binds to digoxin in the bloodstream and neutralizes it. Beyond this antidote, treatment involves correcting dangerous potassium levels, managing abnormal heart rhythms, and in some cases, preventing further absorption of the drug. The specific combination depends on whether the toxicity is acute (an overdose) or chronic (a gradual buildup over time).
Digoxin-Specific Antibody Fragments: The Main Antidote
Digoxin-specific antibody fragments (sold under the brand name DigiFab) are the first-choice treatment for serious digoxin toxicity. These antibody fragments work by binding directly to digoxin molecules in the blood, pulling them away from heart tissue and allowing the body to excrete them. The treatment is given intravenously and typically begins working within 30 minutes.
The antidote is indicated when digoxin toxicity causes any of the following:
- Life-threatening heart rhythm problems, including cardiac arrest
- Potassium levels above 5.0 mEq/L, which signals a poor prognosis without treatment
- Acute ingestion of more than 10 mg in adults or 4 mg in children
- Blood digoxin levels above 12 ng/mL, or above 1.6 ng/mL with significant symptoms
For context, the normal therapeutic range for digoxin is 0.6 to 1.2 ng/mL. Levels at or above 4.0 ng/mL are considered potentially life-threatening.
How Dosing Is Calculated
If someone swallowed a known amount of digoxin, the number of antidote vials is calculated by dividing the total milligrams ingested by 0.5. For digoxin tablets specifically, the ingested amount is first multiplied by 0.8 to account for how much the body actually absorbs. So if someone took 10 mg of digoxin tablets, the calculation would be (10 × 0.8) / 0.5, or 16 vials.
For chronic toxicity where the blood level is known but the amount ingested isn’t, a different formula applies: multiply the serum digoxin concentration (in ng/mL) by the patient’s weight in kilograms, then divide by 100. A 70 kg person with a level of 4 ng/mL would need roughly 3 vials.
Managing High Potassium
Digoxin works by blocking a pump on cell membranes that normally moves potassium into cells. When digoxin levels get too high, this pump shuts down across the body, especially in skeletal muscle, which acts as a massive potassium reservoir. The result is that potassium floods into the bloodstream, and dangerously high potassium (hyperkalemia) becomes one of the most immediate threats to survival.
Potassium above 5.0 mEq/L in the setting of digoxin toxicity is itself a strong reason to give the antibody antidote, because hyperkalemia in these patients is closely linked to fatal outcomes. Treating the digoxin toxicity with antibody fragments addresses the potassium problem at its source by restoring normal pump function.
One critical caution: intravenous calcium, which is normally a go-to treatment for dangerous hyperkalemia, is controversial when digoxin is involved. Digoxin already causes calcium to build up inside heart muscle cells. Adding more calcium on top of that could theoretically push the heart into an irreversible state of contraction, sometimes called “stone heart syndrome,” where the muscle locks up and cannot relax. Some studies have found no significant increase in mortality from giving calcium to patients with digoxin toxicity, but given the theoretical risk and case reports suggesting harm, most clinicians avoid it when possible and reach for the antibody fragments instead.
Treating Heart Rhythm Problems
Digoxin toxicity can cause an unusually wide range of heart rhythm disturbances. These include slow heart rates (bradycardia), all degrees of heart block (where electrical signals between the upper and lower chambers are delayed or stopped), premature heartbeats originating from the ventricles, and ventricular tachycardia. One particularly distinctive pattern is bidirectional ventricular tachycardia, where the heart’s electrical axis flips back and forth with each beat. This rhythm is rare enough that when it shows up, digoxin toxicity is high on the list of causes.
For slow heart rhythms, atropine is the initial treatment. It works by blocking the vagus nerve’s slowing effect on the heart. Certain medications that would normally be used to speed up the heart, like adrenaline (epinephrine), are specifically avoided because they can trigger ventricular fibrillation in a digoxin-toxic heart.
For fast ventricular rhythms, lidocaine or magnesium sulfate can be used alongside the antibody antidote. If the heart rate remains dangerously slow despite atropine, temporary cardiac pacing may be necessary, but this carries extra risk in digoxin toxicity and is reserved for situations where the antidote isn’t immediately available. Pacing requires a specialized cardiac care setting because the irritable heart tissue can respond unpredictably to electrical stimulation.
Activated Charcoal for Recent Ingestion
If someone has recently swallowed a large amount of digoxin, activated charcoal can reduce how much of the drug gets absorbed from the gut. Charcoal works by binding to the digoxin in the stomach and intestines before it enters the bloodstream. It is most effective when given within one to two hours of ingestion. After that window, most of the drug has already been absorbed, and charcoal provides little benefit. Charcoal is only a supplemental measure and does not replace the antibody antidote in serious cases.
How Toxicity Is Recognized
Knowing what to give for digoxin toxicity depends on recognizing it in the first place. The classic early symptoms are gastrointestinal: nausea, vomiting, loss of appetite, and abdominal pain. Visual disturbances are also characteristic, including blurred vision, seeing halos around lights, or changes in color perception (often a yellow or green tint).
On an ECG, digoxin use produces a distinctive “reverse tick” pattern in the ST segment, a scooped or sagging appearance most visible in certain leads. This pattern alone doesn’t mean toxicity, as it can appear at therapeutic levels too. What signals actual toxicity is the appearance of new arrhythmias on top of that baseline pattern: frequent premature ventricular beats, an unusually regular ventricular rate in someone with atrial fibrillation (suggesting the normal conduction system has been overridden), or the bidirectional ventricular tachycardia mentioned earlier.
Blood digoxin levels help confirm the diagnosis but don’t tell the whole story. Patients with kidney problems, low potassium, low magnesium, or advanced age can develop toxicity even at levels within or near the therapeutic range. The clinical picture, especially the combination of GI symptoms, visual changes, and new rhythm disturbances, matters as much as the number on the lab report.